Corporate Banner
Satellite Banner
Proteomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SCIENION and Innopsys Agree on a Joint Product Offering for RPPA

Published: Tuesday, March 26, 2013
Last Updated: Monday, March 25, 2013
Bookmark and Share
Added value for customers combining technologies of both companies into a complete assay solution.

SCIENION AG and Innopsys have announced a cooperation agreement on a seamless integration of its microarray production and detection equipment.

Combining technologies of both companies will benefit our customers for a broad range of applications. A good example is “reverse phase protein array” (RPPA).

RPPA is a high-throughput antibody-based technique developed for functional proteomics studies to evaluate protein activities in biological networks.

This is useful in identifying drug selectivity, classifying tumors, predicting responses to target therapies, and many more. Lysates from cultured cells or patient tissue samples are typically deposited and incubated on nitrocellulose membranes.

Scienion’s sciFLEXARRAYER technology can precisely and gently print lysates on nitrocellulose coated glass slides without damage to the surface.

Innopsys InnoScan® 710-IR near infrared scanner is the only product that allows for an IR detection readout of these arrays. It combines a 3µm per pixel resolution with 670 nm and 785 nm excitation lasers, a spectral range where the auto-fluorescence of nitrocellulose that is typically present in the visible range is significantly decreased.

This product combination will significantly improve signal to noise ratios. Systems will be offered as full out-of-the-box solutions, where equipment and software have been configured to execute RPPA assays from A to Z. This will lower the barrier of entry, allowing more researchers to experiment with RPPA.

Dr. Holger Eickhoff, CEO of SCIENION AG, states: “We are very pleased to offer a complete solution that integrates Innopsys’ high resolution scanners, especially its unique IR detection devices. The InnoScan® products complement our own colorimetric scanner sciREADER CL. Our customers will benefit from combining state-of-the-art printing and detection technologies of both companies, including full configuration and software integration, enabling advance performance and automation for such multiplex assays.”

Dr. Laurence BOUET, Executive and Sales Director of INNOPSYS, comments: “SCIENION and Innopsys focus on top quality and high performance products and we target the same clientele. I view our initial collaboration as an ideal match of partners. We appreciate this new cooperation as a promising opportunity to scale up outreach and we look forward to identify further areas for joint activities.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
New Weapon Against Hard-to-Treat Bacterial Infections
Using peptides, researchers have been able to prevent drug-resistance bacteria from forming abscesses.
Death-or-Repair Switch Protein Identified
Researchers have identified a protein that plays a key role in the decision process of cell damage repair or cellular suicide.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Gene Deletion Reveals Cell Secrets
Researchers have deleted 174 genes in yeast to analyse the effect of individual gene deletion.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!